Martin George Kelly 4
4 · TriSalus Life Sciences, Inc. · Filed Sep 10, 2024
Insider Transaction Report
Form 4
Martin George Kelly
Director
Transactions
- Sale
Common Stock
2024-08-28$5.50/sh−9$50→ 247,176 total(indirect: By LLC)
Footnotes (1)
- [F1]The shares are held by Varka LLC. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Varka LLC.